Tirapazamine

Suppliers

Names

[ CAS No. ]:
27314-97-2

[ Name ]:
Tirapazamine

[Synonym ]:
4-hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine
1,2,4-Benzotriazin-3-amine, 1,4-dioxide
3-Amino-1,2,4-benzotriazine 1,4-Dioxide
1,4-Dioxido-1,2,4-benzotriazin-3-ylamine
SR 259075
1,2,4-Benzotriazin-3-amine 1,4-dioxide
4-Hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine SR 259075 SR 4233 Tirazone Win 59075
Tirazone
Tirapazamine
3-Aminobenzo[e][1,2,4]triazine 1,4-dioxide

Chemical & Physical Properties

[ Density]:
1.7±0.1 g/cm3

[ Boiling Point ]:
493.6±28.0 °C at 760 mmHg

[ Melting Point ]:
220ºC

[ Molecular Formula ]:
C7H6N4O2

[ Molecular Weight ]:
178.148

[ Flash Point ]:
252.3±24.0 °C

[ Exact Mass ]:
178.049072

[ PSA ]:
89.83000

[ LogP ]:
-0.31

[ Vapour Pressure ]:
0.0±1.3 mmHg at 25°C

[ Index of Refraction ]:
1.777

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DM0671500
CHEMICAL NAME :
1,2,4-Benzotriazine, 3-amino-, 1,4-dioxide
CAS REGISTRY NUMBER :
27314-97-2
BEILSTEIN REFERENCE NO. :
0179322
LAST UPDATED :
199712
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C7-H6-N4-O2
MOLECULAR WEIGHT :
178.17

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
59390 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>36 mg/kg
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Endocrine - other changes Blood - changes in bone marrow (not otherwise specified)
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
89 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
101 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Skin and Appendages - hair Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
19 mg/kg/2W-C
TOXIC EFFECTS :
Related to Chronic Data - death

MUTATION DATA

TYPE OF TEST :
Unscheduled DNA synthesis
TEST SYSTEM :
Rodent - rat Mammary gland
DOSE/DURATION :
500 umol/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 11,1407,1990

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
36/37/38

[ Safety Phrases ]:
26-36

[ RIDADR ]:
NONH for all modes of transport

[ RTECS ]:
DM0671500

Synthetic Route

Precursor & DownStream

Precursor

  • 1-oxido-1,2,4-benzotriazin-1-ium-3-amine
  • 1,2,4-benzotriazin-3-amine
  • 2-Nitroaniline
  • 1,2-Dinitrobenzene
  • 1,2,4-Benzotriazine,3-chloro-, 1-oxide
  • 3-hydroxy-1,2,4-benzotriazine 1-oxide

DownStream

  • 1-oxido-1,2,4-benzotriazin-1-ium-3-amine
  • (4S,5R)-4-Hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one
  • 1,2,4-benzotriazin-3-amine

Articles

An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior.

J. Biomed. Mater. Res. B. Appl. Biomater. 103(3) , 618-28, (2015)

Three-dimensional (3-D) tissue engineered constructs provide a platform for examining how the local extracellular matrix contributes to the malignancy of various cancers, including human glioblastoma ...

Tirapazamine-doxorubicin interaction referring to heart oxidative stress and Ca²⁺ balance protein levels.

Oxid. Med. Cell. Longev. 2012 , 890826, (2012)

Doxorubicin (DOX) causes long-term cardiomyopathy that is dependent on oxidative stress and contractility disorders. Tirapazamine (TP), an experimental adjuvant drug, passes the same red-ox transforma...

Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.

Br. J. Cancer 77 Suppl 4 , 12-4, (1998)

Human solid tumours are composed of a significant proportion of hypoxic cells, i.e. cells with oxygen levels lower than those of normal tissues. Tumour hypoxic cells have been shown to have a negative...


More Articles


Related Compounds

  • Tirapazamine
  • 2-Methoxy-3-[4-(methoxycarbonyl)phenyl]propanoic acid
  • 1-[1-(Furan-2-yl)prop-1-en-2-yl]-2,2-dimethylcyclopropan-1-amine
  • 4-{[Hydroxy(methyl)amino]methyl}-2,6-dimethoxyphenol
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 3-ethoxy-4-{[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1,2,5-oxadiazol-3-yl]formamido}butanoic acid
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide